Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial

Figures

• 

  FIGURE 1. Subanalysis flowchart.

• 

  FIGURE 2. Development of an interdisciplinary consolidated medication plan after comparing the drug information in the medication plan documented by the study physician with the results of the interview between the pharmacist and the patient in a medication review. CMP, consolidated medication plan; MP, medication plan.

• 

  FIGURE 3. (A) Impact of interdisciplinary consolidation on the physician-documented drug regimen of heart failure patients (n = 926 drugs*). *Fifty-nine drugs identified only in the patient interview were not included in Analysis I. CMP, consolidated medication plan; MP, medication plan. (B) Changes in the drug regimen resulting from the medication review (n = 303 drugs). Variations in the percentages or from 100% are due to rounding deviations in values.

• 

  FIGURE 4. (A) Impact of the interdisciplinary consolidation on the heart failure medication (n = 304 drugs). (B) Changes in the heart failure medication (n = 92 drugs). Variations in the percentages are due to rounding deviations in values.

• 

  FIGURE 5. Modifications in the heart failure medication comparing the physician’s medication plan (MP) and the consolidated medication plan (CMP).